These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11277695)
1. Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells. Smahel M; Síma P; Ludvíková V; Vonka V Virology; 2001 Mar; 281(2):231-8. PubMed ID: 11277695 [TBL] [Abstract][Full Text] [Related]
2. Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect. Pokorná D; Macková J; Dusková M; Rittich S; Ludvíková V; Smahel M J Gene Med; 2005 Jun; 7(6):696-707. PubMed ID: 15712328 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of immunogenicity of HPV16 E7 oncogene by fusion with E. coli beta-glucuronidase. Smahel M; Pokorná D; Macková J; Vlasák J J Gene Med; 2004 Oct; 6(10):1092-101. PubMed ID: 15386741 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein. Smahel M; Poláková I; Pokorná D; Ludvíková V; Dusková M; Vlasák J Int J Oncol; 2008 Jul; 33(1):93-101. PubMed ID: 18575754 [TBL] [Abstract][Full Text] [Related]
5. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection. Cheung YK; Cheng SC; Sin FW; Xie Y Vaccine; 2004 Dec; 23(5):629-38. PubMed ID: 15542183 [TBL] [Abstract][Full Text] [Related]
6. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response. Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545 [TBL] [Abstract][Full Text] [Related]
7. [Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice]. Tian HW; Ye ZM; Lu ZH; Jao R; Bian T; Zhao L; Ruan L Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):33-7. PubMed ID: 16816859 [TBL] [Abstract][Full Text] [Related]
8. Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs. Chen CH; Ji H; Suh KW; Choti MA; Pardoll DM; Wu TC Gene Ther; 1999 Dec; 6(12):1972-81. PubMed ID: 10637448 [TBL] [Abstract][Full Text] [Related]
9. DNA vaccines based on chimeric potyvirus-like particles carrying HPV16 E7 peptide (aa 44-60). Pokorna D; Cerovska N; Smahel M; Moravec T; Ludvikova V; Mackova J; Synkova H; Duskova M; Hozak P; Veleminsky J Oncol Rep; 2005 Oct; 14(4):1045-53. PubMed ID: 16142370 [TBL] [Abstract][Full Text] [Related]
10. A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses. Yan Q; Cheung YK; Cheng SC; Wang XH; Shi M; Hu MH; Yong X Gynecol Oncol; 2007 Jan; 104(1):199-206. PubMed ID: 17049969 [TBL] [Abstract][Full Text] [Related]
11. Comparison of HPV DNA vaccines employing intracellular targeting strategies. Kim JW; Hung CF; Juang J; He L; Kim TW; Armstrong DK; Pai SI; Chen PJ; Lin CT; Boyd DA; Wu TC Gene Ther; 2004 Jun; 11(12):1011-8. PubMed ID: 14985791 [TBL] [Abstract][Full Text] [Related]
12. DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens. Huang CY; Chen CA; Lee CN; Chang MC; Su YN; Lin YC; Hsieh CY; Cheng WF Gynecol Oncol; 2007 Dec; 107(3):404-12. PubMed ID: 17905417 [TBL] [Abstract][Full Text] [Related]
13. Combined immunization with DNA and transduced tumor cells expressing mouse GM-CSF or IL-2. Rittich S; Duskova M; Mackova J; Pokorna D; Jinoch P; Smahel M Oncol Rep; 2005 Feb; 13(2):311-7. PubMed ID: 15643517 [TBL] [Abstract][Full Text] [Related]
14. Combination of intratumoral injections of vaccinia virus MVA expressing GM-CSF and immunization with DNA vaccine prolongs the survival of mice bearing HPV16 induced tumors with downregulated expression of MHC class I molecules. Nemeckova S; Smahel M; Hainz P; Mackova J; Zurkova K; Gabriel P; Indrova M; Kutinova L Neoplasma; 2007; 54(4):326-33. PubMed ID: 17822323 [TBL] [Abstract][Full Text] [Related]
16. Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7. Daemen T; Pries F; Bungener L; Kraak M; Regts J; Wilschut J Gene Ther; 2000 Nov; 7(21):1859-66. PubMed ID: 11110419 [TBL] [Abstract][Full Text] [Related]
17. Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination. Michel N; Osen W; Gissmann L; Schumacher TN; Zentgraf H; Müller M Virology; 2002 Mar; 294(1):47-59. PubMed ID: 11886264 [TBL] [Abstract][Full Text] [Related]
18. Animal models for development of therapeutic HPV16 vaccines (review). Bubeník J Int J Oncol; 2002 Jan; 20(1):207-12. PubMed ID: 11743666 [TBL] [Abstract][Full Text] [Related]
19. A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity. Lin CT; Tsai YC; He L; Calizo R; Chou HH; Chang TC; Soong YK; Hung CF; Lai CH J Biomed Sci; 2006 Jul; 13(4):481-8. PubMed ID: 16649071 [TBL] [Abstract][Full Text] [Related]
20. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene. Chen CH; Wang TL; Ji H; Hung CF; Pardoll DM; Cheng WF; Ling M; Wu TC Gene Ther; 2001 Jan; 8(2):128-38. PubMed ID: 11313782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]